nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—Alkylating Activity—Thiotepa—sarcoma	0.412	0.556	CiPCiCtD
Procarbazine—Alkylating Activity—Dacarbazine—sarcoma	0.329	0.444	CiPCiCtD
Procarbazine—CYP1B1—Mitoxantrone—sarcoma	0.0914	0.481	CbGbCtD
Procarbazine—XDH—Doxorubicin—sarcoma	0.0591	0.312	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—sarcoma	0.0393	0.207	CbGbCtD
Procarbazine—XDH—Effects of Nitric Oxide—MB—sarcoma	0.00515	0.596	CbGpPWpGaD
Procarbazine—XDH—Effects of Nitric Oxide—HBA1—sarcoma	0.00186	0.215	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—HBA1—sarcoma	0.000273	0.0316	CbGpPWpGaD
Procarbazine—CYP1B1—Melatonin metabolism and effects—FOXO1—sarcoma	0.000215	0.0249	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—JUN—sarcoma	0.000213	0.0247	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—MDM2—sarcoma	8.92e-05	0.0103	CbGpPWpGaD
Procarbazine—Purpura—Epirubicin—sarcoma	8.56e-05	0.0014	CcSEcCtD
Procarbazine—Shock—Mitoxantrone—sarcoma	8.56e-05	0.0014	CcSEcCtD
Procarbazine—Pain—Dactinomycin—sarcoma	8.55e-05	0.0014	CcSEcCtD
Procarbazine—Vascular purpura—Doxorubicin—sarcoma	8.54e-05	0.0014	CcSEcCtD
Procarbazine—Thrombocytopenia—Mitoxantrone—sarcoma	8.52e-05	0.00139	CcSEcCtD
Procarbazine—Anorexia—Vincristine—sarcoma	8.51e-05	0.00139	CcSEcCtD
Procarbazine—Tachycardia—Mitoxantrone—sarcoma	8.49e-05	0.00139	CcSEcCtD
Procarbazine—Lethargy—Epirubicin—sarcoma	8.42e-05	0.00138	CcSEcCtD
Procarbazine—Hyperhidrosis—Mitoxantrone—sarcoma	8.41e-05	0.00138	CcSEcCtD
Procarbazine—Hypotension—Vincristine—sarcoma	8.35e-05	0.00137	CcSEcCtD
Procarbazine—Feeling abnormal—Thiotepa—sarcoma	8.3e-05	0.00136	CcSEcCtD
Procarbazine—Anorexia—Mitoxantrone—sarcoma	8.29e-05	0.00136	CcSEcCtD
Procarbazine—Diplopia—Epirubicin—sarcoma	8.25e-05	0.00135	CcSEcCtD
Procarbazine—Feeling abnormal—Dactinomycin—sarcoma	8.24e-05	0.00135	CcSEcCtD
Procarbazine—Gastrointestinal pain—Thiotepa—sarcoma	8.24e-05	0.00135	CcSEcCtD
Procarbazine—Anaemia—Etoposide—sarcoma	8.19e-05	0.00134	CcSEcCtD
Procarbazine—Gastrointestinal pain—Dactinomycin—sarcoma	8.18e-05	0.00134	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Vincristine—sarcoma	8.14e-05	0.00133	CcSEcCtD
Procarbazine—Hypotension—Mitoxantrone—sarcoma	8.13e-05	0.00133	CcSEcCtD
Procarbazine—Insomnia—Vincristine—sarcoma	8.08e-05	0.00132	CcSEcCtD
Procarbazine—Paraesthesia—Vincristine—sarcoma	8.02e-05	0.00131	CcSEcCtD
Procarbazine—Urticaria—Thiotepa—sarcoma	8e-05	0.00131	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	7.97e-05	0.00923	CbGpPWpGaD
Procarbazine—Body temperature increased—Thiotepa—sarcoma	7.96e-05	0.0013	CcSEcCtD
Procarbazine—Abdominal pain—Thiotepa—sarcoma	7.96e-05	0.0013	CcSEcCtD
Procarbazine—Leukopenia—Etoposide—sarcoma	7.94e-05	0.0013	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	7.93e-05	0.0013	CcSEcCtD
Procarbazine—Purpura—Doxorubicin—sarcoma	7.92e-05	0.0013	CcSEcCtD
Procarbazine—Body temperature increased—Dactinomycin—sarcoma	7.9e-05	0.00129	CcSEcCtD
Procarbazine—Abdominal pain—Dactinomycin—sarcoma	7.9e-05	0.00129	CcSEcCtD
Procarbazine—Paraesthesia—Mitoxantrone—sarcoma	7.81e-05	0.00128	CcSEcCtD
Procarbazine—Loss of consciousness—Etoposide—sarcoma	7.79e-05	0.00128	CcSEcCtD
Procarbazine—Lethargy—Doxorubicin—sarcoma	7.79e-05	0.00128	CcSEcCtD
Procarbazine—Decreased appetite—Vincristine—sarcoma	7.77e-05	0.00127	CcSEcCtD
Procarbazine—Ataxia—Epirubicin—sarcoma	7.76e-05	0.00127	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	7.76e-05	0.00898	CbGpPWpGaD
Procarbazine—Cough—Etoposide—sarcoma	7.74e-05	0.00127	CcSEcCtD
Procarbazine—Somnolence—Mitoxantrone—sarcoma	7.73e-05	0.00127	CcSEcCtD
Procarbazine—Fatigue—Vincristine—sarcoma	7.7e-05	0.00126	CcSEcCtD
Procarbazine—Convulsion—Etoposide—sarcoma	7.68e-05	0.00126	CcSEcCtD
Procarbazine—Hypertension—Etoposide—sarcoma	7.65e-05	0.00125	CcSEcCtD
Procarbazine—Pain—Vincristine—sarcoma	7.64e-05	0.00125	CcSEcCtD
Procarbazine—Constipation—Vincristine—sarcoma	7.64e-05	0.00125	CcSEcCtD
Procarbazine—Diplopia—Doxorubicin—sarcoma	7.64e-05	0.00125	CcSEcCtD
Procarbazine—Decreased appetite—Mitoxantrone—sarcoma	7.56e-05	0.00124	CcSEcCtD
Procarbazine—Fatigue—Mitoxantrone—sarcoma	7.5e-05	0.00123	CcSEcCtD
Procarbazine—Pain—Mitoxantrone—sarcoma	7.44e-05	0.00122	CcSEcCtD
Procarbazine—Constipation—Mitoxantrone—sarcoma	7.44e-05	0.00122	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Epirubicin—sarcoma	7.43e-05	0.00122	CcSEcCtD
Procarbazine—Hypersensitivity—Thiotepa—sarcoma	7.42e-05	0.00121	CcSEcCtD
Procarbazine—Hypersensitivity—Dactinomycin—sarcoma	7.37e-05	0.00121	CcSEcCtD
Procarbazine—Gastrointestinal pain—Vincristine—sarcoma	7.3e-05	0.0012	CcSEcCtD
Procarbazine—Confusional state—Etoposide—sarcoma	7.3e-05	0.00119	CcSEcCtD
Procarbazine—Asthenia—Thiotepa—sarcoma	7.23e-05	0.00118	CcSEcCtD
Procarbazine—Infection—Etoposide—sarcoma	7.19e-05	0.00118	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—sarcoma	7.18e-05	0.00118	CcSEcCtD
Procarbazine—Asthenia—Dactinomycin—sarcoma	7.17e-05	0.00117	CcSEcCtD
Procarbazine—Feeling abnormal—Mitoxantrone—sarcoma	7.17e-05	0.00117	CcSEcCtD
Procarbazine—Dysphagia—Epirubicin—sarcoma	7.13e-05	0.00117	CcSEcCtD
Procarbazine—Pruritus—Thiotepa—sarcoma	7.13e-05	0.00117	CcSEcCtD
Procarbazine—Gastrointestinal pain—Mitoxantrone—sarcoma	7.11e-05	0.00116	CcSEcCtD
Procarbazine—Thrombocytopenia—Etoposide—sarcoma	7.08e-05	0.00116	CcSEcCtD
Procarbazine—Tachycardia—Etoposide—sarcoma	7.06e-05	0.00116	CcSEcCtD
Procarbazine—Eosinophilia—Epirubicin—sarcoma	7.06e-05	0.00116	CcSEcCtD
Procarbazine—Body temperature increased—Vincristine—sarcoma	7.06e-05	0.00116	CcSEcCtD
Procarbazine—Abdominal pain—Vincristine—sarcoma	7.06e-05	0.00116	CcSEcCtD
Procarbazine—Hyperhidrosis—Etoposide—sarcoma	7e-05	0.00114	CcSEcCtD
Procarbazine—Pancreatitis—Epirubicin—sarcoma	6.99e-05	0.00114	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—SRC—sarcoma	6.96e-05	0.00805	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	6.96e-05	0.00805	CbGpPWpGaD
Procarbazine—Angina pectoris—Epirubicin—sarcoma	6.95e-05	0.00114	CcSEcCtD
Procarbazine—Urticaria—Mitoxantrone—sarcoma	6.91e-05	0.00113	CcSEcCtD
Procarbazine—Anorexia—Etoposide—sarcoma	6.9e-05	0.00113	CcSEcCtD
Procarbazine—Diarrhoea—Thiotepa—sarcoma	6.89e-05	0.00113	CcSEcCtD
Procarbazine—Abdominal pain—Mitoxantrone—sarcoma	6.88e-05	0.00113	CcSEcCtD
Procarbazine—Body temperature increased—Mitoxantrone—sarcoma	6.88e-05	0.00113	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	6.88e-05	0.00113	CcSEcCtD
Procarbazine—Diarrhoea—Dactinomycin—sarcoma	6.84e-05	0.00112	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	6.78e-05	0.00784	CbGpPWpGaD
Procarbazine—Pancytopenia—Epirubicin—sarcoma	6.77e-05	0.00111	CcSEcCtD
Procarbazine—Hypotension—Etoposide—sarcoma	6.76e-05	0.00111	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	6.69e-05	0.00775	CbGpPWpGaD
Procarbazine—Dizziness—Thiotepa—sarcoma	6.66e-05	0.00109	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—sarcoma	6.6e-05	0.00108	CcSEcCtD
Procarbazine—Pollakiuria—Epirubicin—sarcoma	6.59e-05	0.00108	CcSEcCtD
Procarbazine—Hypersensitivity—Vincristine—sarcoma	6.58e-05	0.00108	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—sarcoma	6.53e-05	0.00107	CcSEcCtD
Procarbazine—Photosensitivity reaction—Epirubicin—sarcoma	6.51e-05	0.00107	CcSEcCtD
Procarbazine—Paraesthesia—Etoposide—sarcoma	6.5e-05	0.00106	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—sarcoma	6.47e-05	0.00106	CcSEcCtD
Procarbazine—Somnolence—Etoposide—sarcoma	6.43e-05	0.00105	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—sarcoma	6.43e-05	0.00105	CcSEcCtD
Procarbazine—Hypersensitivity—Mitoxantrone—sarcoma	6.41e-05	0.00105	CcSEcCtD
Procarbazine—Asthenia—Vincristine—sarcoma	6.41e-05	0.00105	CcSEcCtD
Procarbazine—Vomiting—Thiotepa—sarcoma	6.4e-05	0.00105	CcSEcCtD
Procarbazine—Pneumonia—Epirubicin—sarcoma	6.4e-05	0.00105	CcSEcCtD
Procarbazine—Drowsiness—Epirubicin—sarcoma	6.36e-05	0.00104	CcSEcCtD
Procarbazine—Vomiting—Dactinomycin—sarcoma	6.36e-05	0.00104	CcSEcCtD
Procarbazine—Rash—Thiotepa—sarcoma	6.35e-05	0.00104	CcSEcCtD
Procarbazine—Dermatitis—Thiotepa—sarcoma	6.35e-05	0.00104	CcSEcCtD
Procarbazine—Headache—Thiotepa—sarcoma	6.31e-05	0.00103	CcSEcCtD
Procarbazine—Rash—Dactinomycin—sarcoma	6.3e-05	0.00103	CcSEcCtD
Procarbazine—Decreased appetite—Etoposide—sarcoma	6.29e-05	0.00103	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—sarcoma	6.27e-05	0.00103	CcSEcCtD
Procarbazine—Asthenia—Mitoxantrone—sarcoma	6.24e-05	0.00102	CcSEcCtD
Procarbazine—Fatigue—Etoposide—sarcoma	6.24e-05	0.00102	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—MYC—sarcoma	6.23e-05	0.00722	CbGpPWpGaD
Procarbazine—Neuropathy peripheral—Epirubicin—sarcoma	6.23e-05	0.00102	CcSEcCtD
Procarbazine—Stomatitis—Epirubicin—sarcoma	6.2e-05	0.00101	CcSEcCtD
Procarbazine—Jaundice—Epirubicin—sarcoma	6.2e-05	0.00101	CcSEcCtD
Procarbazine—Pain—Etoposide—sarcoma	6.19e-05	0.00101	CcSEcCtD
Procarbazine—Constipation—Etoposide—sarcoma	6.19e-05	0.00101	CcSEcCtD
Procarbazine—Diarrhoea—Vincristine—sarcoma	6.11e-05	0.001	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	6.1e-05	0.00706	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	6.1e-05	0.00706	CbGpPWpGaD
Procarbazine—Sweating—Epirubicin—sarcoma	6.1e-05	0.000998	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—sarcoma	6.1e-05	0.000998	CcSEcCtD
Procarbazine—Haematuria—Epirubicin—sarcoma	6.06e-05	0.000992	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—sarcoma	6.02e-05	0.000986	CcSEcCtD
Procarbazine—Epistaxis—Epirubicin—sarcoma	6e-05	0.000982	CcSEcCtD
Procarbazine—Nausea—Thiotepa—sarcoma	5.98e-05	0.000979	CcSEcCtD
Procarbazine—Feeling abnormal—Etoposide—sarcoma	5.96e-05	0.000976	CcSEcCtD
Procarbazine—Diarrhoea—Mitoxantrone—sarcoma	5.95e-05	0.000974	CcSEcCtD
Procarbazine—Nausea—Dactinomycin—sarcoma	5.94e-05	0.000972	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—sarcoma	5.92e-05	0.000969	CcSEcCtD
Procarbazine—Gastrointestinal pain—Etoposide—sarcoma	5.92e-05	0.000968	CcSEcCtD
Procarbazine—Dizziness—Vincristine—sarcoma	5.91e-05	0.000967	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—sarcoma	5.88e-05	0.000963	CcSEcCtD
Procarbazine—Neuropathy peripheral—Doxorubicin—sarcoma	5.77e-05	0.000944	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	5.76e-05	0.00667	CbGpPWpGaD
Procarbazine—Urticaria—Etoposide—sarcoma	5.75e-05	0.000941	CcSEcCtD
Procarbazine—Haemoglobin—Epirubicin—sarcoma	5.74e-05	0.000939	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—sarcoma	5.74e-05	0.000939	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—sarcoma	5.74e-05	0.000939	CcSEcCtD
Procarbazine—Body temperature increased—Etoposide—sarcoma	5.72e-05	0.000936	CcSEcCtD
Procarbazine—Abdominal pain—Etoposide—sarcoma	5.72e-05	0.000936	CcSEcCtD
Procarbazine—Haemorrhage—Epirubicin—sarcoma	5.71e-05	0.000934	CcSEcCtD
Procarbazine—Vomiting—Vincristine—sarcoma	5.68e-05	0.000929	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—sarcoma	5.64e-05	0.000923	CcSEcCtD
Procarbazine—Rash—Vincristine—sarcoma	5.63e-05	0.000922	CcSEcCtD
Procarbazine—Dermatitis—Vincristine—sarcoma	5.63e-05	0.000921	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—sarcoma	5.61e-05	0.000918	CcSEcCtD
Procarbazine—Headache—Vincristine—sarcoma	5.6e-05	0.000916	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—sarcoma	5.55e-05	0.000908	CcSEcCtD
Procarbazine—Vomiting—Mitoxantrone—sarcoma	5.53e-05	0.000905	CcSEcCtD
Procarbazine—Rash—Mitoxantrone—sarcoma	5.49e-05	0.000898	CcSEcCtD
Procarbazine—Dermatitis—Mitoxantrone—sarcoma	5.48e-05	0.000897	CcSEcCtD
Procarbazine—Headache—Mitoxantrone—sarcoma	5.45e-05	0.000892	CcSEcCtD
Procarbazine—Hypersensitivity—Etoposide—sarcoma	5.33e-05	0.000872	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—sarcoma	5.31e-05	0.000869	CcSEcCtD
Procarbazine—Nausea—Vincristine—sarcoma	5.31e-05	0.000868	CcSEcCtD
Procarbazine—Flushing—Epirubicin—sarcoma	5.3e-05	0.000867	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—sarcoma	5.28e-05	0.000865	CcSEcCtD
Procarbazine—Asthenia—Etoposide—sarcoma	5.19e-05	0.00085	CcSEcCtD
Procarbazine—Nausea—Mitoxantrone—sarcoma	5.17e-05	0.000846	CcSEcCtD
Procarbazine—Chills—Epirubicin—sarcoma	5.12e-05	0.000838	CcSEcCtD
Procarbazine—Pruritus—Etoposide—sarcoma	5.12e-05	0.000838	CcSEcCtD
Procarbazine—Arrhythmia—Epirubicin—sarcoma	5.1e-05	0.000835	CcSEcCtD
Procarbazine—Alopecia—Epirubicin—sarcoma	5.05e-05	0.000826	CcSEcCtD
Procarbazine—Diarrhoea—Etoposide—sarcoma	4.95e-05	0.00081	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—sarcoma	4.9e-05	0.000802	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	4.9e-05	0.00567	CbGpPWpGaD
Procarbazine—Tension—Epirubicin—sarcoma	4.88e-05	0.000798	CcSEcCtD
Procarbazine—Nervousness—Epirubicin—sarcoma	4.83e-05	0.00079	CcSEcCtD
Procarbazine—Dizziness—Etoposide—sarcoma	4.79e-05	0.000783	CcSEcCtD
Procarbazine—Chills—Doxorubicin—sarcoma	4.74e-05	0.000776	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—sarcoma	4.72e-05	0.000772	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—sarcoma	4.67e-05	0.000764	CcSEcCtD
Procarbazine—Vomiting—Etoposide—sarcoma	4.6e-05	0.000753	CcSEcCtD
Procarbazine—Anaemia—Epirubicin—sarcoma	4.59e-05	0.000752	CcSEcCtD
Procarbazine—Rash—Etoposide—sarcoma	4.56e-05	0.000747	CcSEcCtD
Procarbazine—Dermatitis—Etoposide—sarcoma	4.56e-05	0.000746	CcSEcCtD
Procarbazine—Headache—Etoposide—sarcoma	4.53e-05	0.000742	CcSEcCtD
Procarbazine—Tension—Doxorubicin—sarcoma	4.51e-05	0.000738	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—sarcoma	4.47e-05	0.000731	CcSEcCtD
Procarbazine—Syncope—Epirubicin—sarcoma	4.46e-05	0.000729	CcSEcCtD
Procarbazine—Leukopenia—Epirubicin—sarcoma	4.45e-05	0.000728	CcSEcCtD
Procarbazine—Loss of consciousness—Epirubicin—sarcoma	4.37e-05	0.000715	CcSEcCtD
Procarbazine—Cough—Epirubicin—sarcoma	4.34e-05	0.00071	CcSEcCtD
Procarbazine—Convulsion—Epirubicin—sarcoma	4.31e-05	0.000705	CcSEcCtD
Procarbazine—Nausea—Etoposide—sarcoma	4.3e-05	0.000703	CcSEcCtD
Procarbazine—Hypertension—Epirubicin—sarcoma	4.29e-05	0.000702	CcSEcCtD
Procarbazine—Anaemia—Doxorubicin—sarcoma	4.25e-05	0.000696	CcSEcCtD
Procarbazine—Myalgia—Epirubicin—sarcoma	4.23e-05	0.000692	CcSEcCtD
Procarbazine—Arthralgia—Epirubicin—sarcoma	4.23e-05	0.000692	CcSEcCtD
Procarbazine—Anxiety—Epirubicin—sarcoma	4.22e-05	0.00069	CcSEcCtD
Procarbazine—Dry mouth—Epirubicin—sarcoma	4.14e-05	0.000677	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—sarcoma	4.12e-05	0.000675	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—sarcoma	4.12e-05	0.000674	CcSEcCtD
Procarbazine—Confusional state—Epirubicin—sarcoma	4.09e-05	0.000669	CcSEcCtD
Procarbazine—Oedema—Epirubicin—sarcoma	4.06e-05	0.000664	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—sarcoma	4.04e-05	0.000661	CcSEcCtD
Procarbazine—Infection—Epirubicin—sarcoma	4.03e-05	0.000659	CcSEcCtD
Procarbazine—Cough—Doxorubicin—sarcoma	4.01e-05	0.000657	CcSEcCtD
Procarbazine—Shock—Epirubicin—sarcoma	3.99e-05	0.000653	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—sarcoma	3.98e-05	0.000652	CcSEcCtD
Procarbazine—Thrombocytopenia—Epirubicin—sarcoma	3.97e-05	0.00065	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—sarcoma	3.97e-05	0.00065	CcSEcCtD
Procarbazine—Tachycardia—Epirubicin—sarcoma	3.96e-05	0.000648	CcSEcCtD
Procarbazine—Hyperhidrosis—Epirubicin—sarcoma	3.92e-05	0.000642	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—sarcoma	3.92e-05	0.000641	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—sarcoma	3.92e-05	0.000641	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—sarcoma	3.9e-05	0.000638	CcSEcCtD
Procarbazine—Anorexia—Epirubicin—sarcoma	3.87e-05	0.000633	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—sarcoma	3.83e-05	0.000627	CcSEcCtD
Procarbazine—Hypotension—Epirubicin—sarcoma	3.79e-05	0.00062	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—sarcoma	3.78e-05	0.000619	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—sarcoma	3.75e-05	0.000614	CcSEcCtD
Procarbazine—Infection—Doxorubicin—sarcoma	3.73e-05	0.00061	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Epirubicin—sarcoma	3.7e-05	0.000605	CcSEcCtD
Procarbazine—Shock—Doxorubicin—sarcoma	3.69e-05	0.000604	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—sarcoma	3.67e-05	0.000601	CcSEcCtD
Procarbazine—Insomnia—Epirubicin—sarcoma	3.67e-05	0.0006	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—sarcoma	3.66e-05	0.000599	CcSEcCtD
Procarbazine—Paraesthesia—Epirubicin—sarcoma	3.64e-05	0.000596	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—sarcoma	3.63e-05	0.000594	CcSEcCtD
Procarbazine—Somnolence—Epirubicin—sarcoma	3.61e-05	0.00059	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—sarcoma	3.58e-05	0.000585	CcSEcCtD
Procarbazine—Decreased appetite—Epirubicin—sarcoma	3.53e-05	0.000577	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—sarcoma	3.51e-05	0.000574	CcSEcCtD
Procarbazine—Fatigue—Epirubicin—sarcoma	3.5e-05	0.000572	CcSEcCtD
Procarbazine—Pain—Epirubicin—sarcoma	3.47e-05	0.000568	CcSEcCtD
Procarbazine—Constipation—Epirubicin—sarcoma	3.47e-05	0.000568	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—sarcoma	3.42e-05	0.00056	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—sarcoma	3.39e-05	0.000556	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—sarcoma	3.37e-05	0.000552	CcSEcCtD
Procarbazine—Feeling abnormal—Epirubicin—sarcoma	3.34e-05	0.000547	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—sarcoma	3.34e-05	0.000546	CcSEcCtD
Procarbazine—Gastrointestinal pain—Epirubicin—sarcoma	3.32e-05	0.000543	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—sarcoma	3.26e-05	0.000534	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—sarcoma	3.24e-05	0.00053	CcSEcCtD
Procarbazine—Urticaria—Epirubicin—sarcoma	3.22e-05	0.000527	CcSEcCtD
Procarbazine—Pain—Doxorubicin—sarcoma	3.21e-05	0.000525	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—sarcoma	3.21e-05	0.000525	CcSEcCtD
Procarbazine—Body temperature increased—Epirubicin—sarcoma	3.21e-05	0.000525	CcSEcCtD
Procarbazine—Abdominal pain—Epirubicin—sarcoma	3.21e-05	0.000525	CcSEcCtD
Procarbazine—Feeling abnormal—Doxorubicin—sarcoma	3.09e-05	0.000506	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—sarcoma	3.07e-05	0.000502	CcSEcCtD
Procarbazine—Hypersensitivity—Epirubicin—sarcoma	2.99e-05	0.000489	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—sarcoma	2.98e-05	0.000488	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—sarcoma	2.97e-05	0.000486	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—sarcoma	2.97e-05	0.000486	CcSEcCtD
Procarbazine—Asthenia—Epirubicin—sarcoma	2.91e-05	0.000476	CcSEcCtD
Procarbazine—Pruritus—Epirubicin—sarcoma	2.87e-05	0.00047	CcSEcCtD
Procarbazine—Diarrhoea—Epirubicin—sarcoma	2.78e-05	0.000454	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—sarcoma	2.77e-05	0.000453	CcSEcCtD
Procarbazine—XDH—Metabolism—ENO2—sarcoma	2.75e-05	0.00318	CbGpPWpGaD
Procarbazine—XDH—Metabolism—HBA1—sarcoma	2.73e-05	0.00316	CbGpPWpGaD
Procarbazine—Asthenia—Doxorubicin—sarcoma	2.69e-05	0.000441	CcSEcCtD
Procarbazine—Dizziness—Epirubicin—sarcoma	2.68e-05	0.000439	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—sarcoma	2.66e-05	0.000435	CcSEcCtD
Procarbazine—Vomiting—Epirubicin—sarcoma	2.58e-05	0.000422	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—sarcoma	2.57e-05	0.00042	CcSEcCtD
Procarbazine—Rash—Epirubicin—sarcoma	2.56e-05	0.000419	CcSEcCtD
Procarbazine—Dermatitis—Epirubicin—sarcoma	2.56e-05	0.000418	CcSEcCtD
Procarbazine—Headache—Epirubicin—sarcoma	2.54e-05	0.000416	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—sarcoma	2.48e-05	0.000406	CcSEcCtD
Procarbazine—Nausea—Epirubicin—sarcoma	2.41e-05	0.000394	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—sarcoma	2.39e-05	0.000391	CcSEcCtD
Procarbazine—Rash—Doxorubicin—sarcoma	2.37e-05	0.000387	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—sarcoma	2.36e-05	0.000387	CcSEcCtD
Procarbazine—Headache—Doxorubicin—sarcoma	2.35e-05	0.000385	CcSEcCtD
Procarbazine—XDH—Metabolism—PLCG1—sarcoma	2.33e-05	0.0027	CbGpPWpGaD
Procarbazine—Nausea—Doxorubicin—sarcoma	2.23e-05	0.000365	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—ENO2—sarcoma	1.47e-05	0.0017	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—HBA1—sarcoma	1.46e-05	0.00169	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PLCG1—sarcoma	1.25e-05	0.00144	CbGpPWpGaD
